In pancreatic cancer, the progression from minimally dysplastic epithelium to invasive carcinoma accompanied with the consecutive accumulation of mutations that include activation of oncogenes and inactivation of the tumor-suppressor genes like TP53 [10, 11, 19]. Here, TP53 is linked to pancreatic neoplasm.